Global Sleep Apnea Devices Market Dynamics:

DRIVER: Large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market

The massive pool of undiagnosed patients of sleep apnea holds tremendous potential for the sleep apnea devices market. It is expected with the ongoing awareness campaigns and efforts, the untouched patients base would be diagnosed and treated for the sleep apnea. The increasing trend of oral appliances and home sleep care for the management of sleep apnea are pushing the growth of the market. Over past few years, there is an increasing number of companies venturing into the sleep apnea market.

Projected Growth in Revenue Generation:

The sleep apnea treatment market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.

RESTRAINT: The high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls

The high expenses of the CPAP machines are burden to the patients of sleep apnea, the expenses of these machines are sparsely covered by Medicare in the US, while other countries don’t cover any cost of CPAP. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy creates a huge hurdle for patients.

OPPORTUNITY: Growing demand for home sleep apnea tests (HSATs), and increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence

People are opting more for the home sleep apnea tests (HSATs) due to their affordability and comfort of sleep apnea management at home. The telemedicine has witnessed a surge in the demand maid the pandemic. The incoming advanced technologies in the domain of sleep apnea devices such as Artificial Intelligence (AI) are also creating more opportunities for the market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

COVID-19 impact on the sleep apnea devices market

The growth of the sleep apnea devices market has massively increased due to the sudden outbreak of the COVID-19 pandemic. In the first quarter of 2020, companies faced certain operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and the adverse impact of the virus on sleep apnea patients led to a rise in the demand for and production of sleep apnea devices, such as PAP devices, masks, and sleep ventilators.

Lockdowns in nations across the globe increased the adoption of home sleep apnea tests (HSATs) over PSG devices. Telemedicine and teleconsultations also gained popularity during the pandemic, which further supported the growth of the market. However, with the launch of various COVID-19 vaccines, it can be expected that the incidence of COVID-19 will decline gradually, and the market will continue to grow at a normal pace in the coming five years.

Sleep laboratories & hospitals account for the largest share of the Sleep Apnea Treatment Market in 2020. The home care settings/individuals’ segment is expected to grow at the fastest rate during the forecast period.

Based on end users, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the sleep apnea devices market in 2020. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR during the forecast period. This is attributed to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

North America was the largest regional market for the Sleep Apnea Treatment Market in 2020

The Sleep Apnea Devices Market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and Rest of the world (Latin America, and the Middle East & Africa). North America was the largest regional market for Sleep Apnea Devices Market in 2020. The large share of the North American market can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Emerging APAC economies such as Japan, Australia and China are expected to see significant growth due the increasing prevalence of sleep apnea, the presence of a large undiagnosed patient pool in countries such as India, strategic agreements between global market leaders and regional players, and initiatives undertaken by governments and other private organizations to raise awareness on sleep disorders in several Asia Pacific countries are driving the market for sleep apnea devices in the region.

Key Players:

The global Sleep Apnea Treatment Market is consolidated. The prominent players operating in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719